11/10/2010 VHIR supports CAIBER project 11/10/2010 Instituto de Salud Carlos III promoted since 2008 the project of Consortium to Support Biomedical Research Network (CAIBER) as a platform for clinical trials. CAIBER has already included forty of the more powerful and competitive health centers of the country, establishing frameworks for cooperation with the autonomous communities, research centers, pharmaceutical industry and European platforms and infrastructure clinical trials. From Catalonia, the leader in the research community clinic, and from a reference center, as Vall d'Hebron Research Institute, which in recent years has participated in 25% of all clinical trials approved in Spain, the CAIBER creates new and hopeful scenario. Instituto de Salud Carlos III promoted since 2008 the project of Consortium to Support Biomedical Research Network (CAIBER) as a platform for clinical trials. CAIBER has already included forty of the more powerful and competitive health centers of the country, establishing frameworks for cooperation with the autonomous communities, research centers, pharmaceutical industry and European platforms and infrastructure clinical trials. From Catalonia, the leader in the research community clinic, and from a reference center, as Vall d'Hebron Research Institute, which in recent years has participated in 25% of all clinical trials approved in Spain, the CAIBER creates new and hopeful scenario. Twitter LinkedIn Facebook Whatsapp
